Development of silica-encapsulated silver nanoparticles as contrast agents intended for dual-energy mammography

European Radiology

Volumn 26, Issue 9, 2016, Pages 3301-3309

  Karunamuni, Roshan ^a   Naha, Pratap C ^b   Lau, Kristen C ^a   Al Zaki, Ajlan ^a   Popov, Anatoliy V ^b   Delikatny, Edward J ^b   Tsourkas, Andrew ^a   Cormode, David P ^b   Maidment, Andrew D A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Dual energy; Gold; Mammography; Nanoparticles; Silver

Indexed keywords

CONTRAST MEDIUM; MACROGOL; SILICA NANOPARTICLE; SILVER NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG LIVER LEVEL; DRUG SYNTHESIS; DUAL ENERGY MAMMOGRAPHY; FEMALE; IMAGE SUBTRACTION; IN VIVO STUDY; LYMPH NODE; MACROPHAGE; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PLASMA HALF LIFE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SPLEEN; ANIMAL; BREAST TUMOR; CHEMISTRY; DIAGNOSTIC IMAGING; EVALUATION STUDY; HUMAN; IMAGE ENHANCEMENT; IMAGING PHANTOM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MAMMOGRAPHY; MICE; NANOPARTICLES; PHANTOMS, IMAGING; RADIOGRAPHIC IMAGE ENHANCEMENT; SIGNAL-TO-NOISE RATIO; SILICON DIOXIDE; SILVER; SUBTRACTION TECHNIQUE;

EID: 84959173203     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-4152-y     Document Type: Article

References (35)

1. Wang AT, Vachon CM, Brandt KR, Ghosh K (2014) Breast density and breast cancer risk: a practical review. Mayo Clin Proc 89:548–557
2. Chen SC, Carton AK, Albert M, Conant EF, Schnall MD, Maidment ADA (2008) Initial clinical experience with contrast-enhanced digital breast tomosynthesis. Acad Radiol 14:229–238
3. Dromain C, Thibault F, Diekmann F et al (2012) Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study. Breast Cancer Res 14:R94
4. Froeling V, Diekmann F, Renz DM et al (2013) Correlation of contrast agent kinetics between iodinated contrast-enhanced spectral tomosynthesis and gadolinium-enhanced MRI of breast lesions. Eur Radiol 23:1528–1536
5. Jochelson MS, Dershaw DD, Sung JS et al (2013) Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 266:743–751
6. Lewin JM, Isaacs PK, Vance V, Larke FJ (2003) Dual-energy contrast-enhanced digital subtraction mammography: feasibility. Radiology 229:261–268
7. Jochelson M (2014) Contrast-enhanced digital mammography. Radiol Clin N Am 52:609–616
8. Idee JM, Beaufils H, Bonnemain B (1994) Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 8:193–206
9. Stacul F, van der Molen AJ, Reimer P et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541
10. Pan D, Roessl E, Schlomka JP et al (2010) Computed tomography in color: Nanok-enhanced spectral CT molecular imaging. Angew Chem 49:9635–9639
11. Pan D, Schirra CO, Senpan A et al (2012) An early investigation of ytterbium nanocolloids for selective and quantitative “multicolor” spectral CT imaging. ACS Nano 6:3364–3370
12. Allijn IE, Leong W, Tang J et al (2013) Gold nanocrystal labeling allows low density lipoprotein imaging from the subcellular to macroscopic level. ACS Nano 7:9761–9770
13. Cormode DP, Roessl E, Thran A et al (2010) Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology 256:774–782
14. Karunamuni R, Tsourkas A, Maidment ADA (2014) Exploring silver as a contrast agent for contrast-enhanced dual-energy x-ray breast imaging. Br J Radiol 87:20140081
15. Karunamuni R, Zaki AA, Popov AV et al (2012) An examination of silver as a radiographic contrast agent in dual-energy breast x-ray imaging. LNCS - IWDM 7361:418–425
16. Karunamuni R, Maidment ADA (2014) Search for novel contrast materials in dual-energy x-ray breast imaging using theoretical modeling of contrast-to-noise ratio. Phys Med Biol 59:4311–4324
17. Liu J, Hurt RH (2010) Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ Sci Technol 44:2169–2175
18. Torchilin VP (2007) Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 24:1–16
19. Silvert P-Y, Duvauchelle N, Vijayakrishnan V, Elhsissen KT (1996) Preparation of colloidal silver dispersions by the polyol process. J Mater Chem 6:573–577
20. Graf C, Vossen DLJ, Imhof A, van Blaaderen A (2003) A general method to coat colloidal particles with silica. Langmuir 19:6693–6700
21. Blasi F, Oliveira BL, Rietz TA et al (2015) Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for PET imaging of deep vein thrombosis and pulmonary embolism in rats. J Nucl Med 56:1088–1093
22. Cai QY, Kim SH, Choi KS et al (2007) Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Investig Radiol 42:797–806
23. Naha PC, Chhour P, Cormode DP (2015) Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications. Toxicol In Vitro 29:1445–1453
24. Lau KC, Roth S, Maidment ADA (2014) 2D and 3D registration methods for dual-energy contrast-enhanced digital breast tomosynthesis. Proc SPIE 9033, Medical Imaging 2014: Physics of Medical Imaging:90335W
25. Gang GJ, Varon CA, Kashani H et al (2009) Multiscale deformable registration for dual-energy x-ray imaging. Med Phys 36:351–363
26. van Schooneveld MM, Vucic E, Koole R et al (2008) Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 8:2517–2525
27. Koole R, van Schooneveld MM, Hilhorst J et al (2008) Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 19:2471–2479
28. Torchilin VP (2002) PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 54:235–252
29. Klibanov AL, Maruyama K, Beckerleg AM, Torchilin VP, Huang L (1991) Activity of amphipathic poly(ethylene glycol)-5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta 1062:142–148
30. Cormode DP, Skajaa GO, Delshad A et al (2011) A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. Bioconjug Chem 22:353–361
31. Todd DJ, Kay J (2008) Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity. Curr Rheumatol Rep 10:195–204
32. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983
33. Samberg ME, Oldenburg SJ, Monteiro-Riviere NA (2010) Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118:407–413
34. Choi HS, Liu W, Misra P et al (2007) Renal clearance of quantum dots. Nat Biotechnol 25:1165–1170
35. Fitzpatrick JAJ, Andreko SK, Ernst LA, Waggoner AS, Ballou B, Bruchez MP (2009) Long-term persistence and spectral blue shifting of quantum dots in vivo. Nano Lett 9:2736–2741